Neuregulin 1 in neural development, synaptic plasticity and schizophrenia

Lin Mei, Wencheng Xiong

Research output: Contribution to journalReview article

637 Citations (Scopus)

Abstract

Schizophrenia is a highly debilitating mental disorder that affects ∼1% of the general population, yet it continues to be poorly understood. Recent studies have identified variations in several genes that are associated with this disorder in diverse populations, including those that encode neuregulin 1 (NRG1) and its receptor ErbB4. The past few years have witnessed exciting progress in our knowledge of NRG1 and ErbB4 functions and the biological basis of the increased risk for schizophrenia that is potentially conferred by polymorphisms in the two genes. An improved understanding of the mechanisms by which altered function of NRG1 and ErbB4 contributes to schizophrenia might eventually lead to the development of more effective therapeutics.

Original languageEnglish (US)
Pages (from-to)437-452
Number of pages16
JournalNature Reviews Neuroscience
Volume9
Issue number6
DOIs
StatePublished - Jun 9 2008

Fingerprint

Neuregulin-1
Neuronal Plasticity
Schizophrenia
Mental Disorders
Population
Genes
Therapeutics

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

Neuregulin 1 in neural development, synaptic plasticity and schizophrenia. / Mei, Lin; Xiong, Wencheng.

In: Nature Reviews Neuroscience, Vol. 9, No. 6, 09.06.2008, p. 437-452.

Research output: Contribution to journalReview article

Mei, Lin ; Xiong, Wencheng. / Neuregulin 1 in neural development, synaptic plasticity and schizophrenia. In: Nature Reviews Neuroscience. 2008 ; Vol. 9, No. 6. pp. 437-452.
@article{01bf8152e3694e2280e838311e66cc2f,
title = "Neuregulin 1 in neural development, synaptic plasticity and schizophrenia",
abstract = "Schizophrenia is a highly debilitating mental disorder that affects ∼1{\%} of the general population, yet it continues to be poorly understood. Recent studies have identified variations in several genes that are associated with this disorder in diverse populations, including those that encode neuregulin 1 (NRG1) and its receptor ErbB4. The past few years have witnessed exciting progress in our knowledge of NRG1 and ErbB4 functions and the biological basis of the increased risk for schizophrenia that is potentially conferred by polymorphisms in the two genes. An improved understanding of the mechanisms by which altered function of NRG1 and ErbB4 contributes to schizophrenia might eventually lead to the development of more effective therapeutics.",
author = "Lin Mei and Wencheng Xiong",
year = "2008",
month = "6",
day = "9",
doi = "10.1038/nrn2392",
language = "English (US)",
volume = "9",
pages = "437--452",
journal = "Nature Reviews Neuroscience",
issn = "1471-003X",
publisher = "Nature Publishing Group",
number = "6",

}

TY - JOUR

T1 - Neuregulin 1 in neural development, synaptic plasticity and schizophrenia

AU - Mei, Lin

AU - Xiong, Wencheng

PY - 2008/6/9

Y1 - 2008/6/9

N2 - Schizophrenia is a highly debilitating mental disorder that affects ∼1% of the general population, yet it continues to be poorly understood. Recent studies have identified variations in several genes that are associated with this disorder in diverse populations, including those that encode neuregulin 1 (NRG1) and its receptor ErbB4. The past few years have witnessed exciting progress in our knowledge of NRG1 and ErbB4 functions and the biological basis of the increased risk for schizophrenia that is potentially conferred by polymorphisms in the two genes. An improved understanding of the mechanisms by which altered function of NRG1 and ErbB4 contributes to schizophrenia might eventually lead to the development of more effective therapeutics.

AB - Schizophrenia is a highly debilitating mental disorder that affects ∼1% of the general population, yet it continues to be poorly understood. Recent studies have identified variations in several genes that are associated with this disorder in diverse populations, including those that encode neuregulin 1 (NRG1) and its receptor ErbB4. The past few years have witnessed exciting progress in our knowledge of NRG1 and ErbB4 functions and the biological basis of the increased risk for schizophrenia that is potentially conferred by polymorphisms in the two genes. An improved understanding of the mechanisms by which altered function of NRG1 and ErbB4 contributes to schizophrenia might eventually lead to the development of more effective therapeutics.

UR - http://www.scopus.com/inward/record.url?scp=43949084738&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=43949084738&partnerID=8YFLogxK

U2 - 10.1038/nrn2392

DO - 10.1038/nrn2392

M3 - Review article

C2 - 18478032

AN - SCOPUS:43949084738

VL - 9

SP - 437

EP - 452

JO - Nature Reviews Neuroscience

JF - Nature Reviews Neuroscience

SN - 1471-003X

IS - 6

ER -